Patents by Inventor Mehak Gupta
Mehak Gupta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12201727Abstract: The present invention relates to the novel formulation for sustained or delayed release of rohitukine-rich Dysoxylum binectariferum extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract/fraction of rohitukine-rich Dysoxylum binectariferum with polymers has resulted in a sustained release of the extract or fraction over a period of 16-24 hrs. The said formulations are useful in the treatment of inflammatory diseases.Type: GrantFiled: October 13, 2023Date of Patent: January 21, 2025Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCHInventors: Sonali Sandip Bharate, Vikas Kumar, Mehak Gupta, Sumit Gandhi, Ajay Kumar, Sandip Bibishan Bharate, Ram Vishwakarma
-
Patent number: 12023365Abstract: The present invention is related to the novel oral dosage form for sustained release of crocin-1, a active constituent of Crocus sativus extract or fraction and a process for preparing the same wherein the extract is wet-granulated using excipients, biodegradable polymers and/or non-biodegradable polymers alone or in combination. The said formulations are useful for the treatment of chronic inflammatory diseases wherein NLRP3 inflammasome is involved.Type: GrantFiled: October 18, 2018Date of Patent: July 2, 2024Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCHInventors: Sonali Sandip Bharate, Vikas Kumar, Rohit Singh, Sarita Rani, Mehak Gupta, Ajay Kumar, Sandip Bibishan Bharate, Ram Vishwakarma
-
Publication number: 20240041772Abstract: The present invention relates to the novel formulation for sustained or delayed release of rohitukine-rich Dysoxylum binectariferum extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract/fraction of rohitukine-rich Dysoxylum binectariferum with polymers has resulted in a sustained release of the extract or fraction over a period of 16-24 hrs. The said formulations are useful in the treatment of inflammatory diseases.Type: ApplicationFiled: October 13, 2023Publication date: February 8, 2024Inventors: Sonali Sandip Bharate, Vikas Kumar, Mehak Gupta, Sumit Ghandhi, Ajay Kumar, Sandip Bibishan Bharate, Ram Vishwakarma
-
Patent number: 11878075Abstract: The present invention relates to the novel formulation for sustained or delayed release of rohitukine-rich Dysoxylum binectariferum extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract/fraction of rohitukine-rich Dysoxylum binectariferum with polymers has resulted in a sustained release of the extract or fraction over a period of 16-24 hrs. The said formulations are useful in the treatment of inflammatory diseases.Type: GrantFiled: April 18, 2019Date of Patent: January 23, 2024Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCHInventors: Sonali Sandip Bharate, Vikas Kumar, Mehak Gupta, Sumit Gandhi, Ajay Kumar, Sandip Bibishan Bharate, Ram Vishwakarma
-
Patent number: 11446346Abstract: The present invention is related to a novel gastroretentive swellable oral dosage form for sustained or delayed release of bergenin, a active constituent of Bergenia ciliata extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract of bergenin-rich Bergenia ciliata with polymers has resulted in a sustained release of extract in the stomach over a period of 16-24 hrs. The said formulations are useful for the treatment of inflammatory diseases.Type: GrantFiled: September 11, 2018Date of Patent: September 20, 2022Assignee: Council of Scientific & Industrial ResearchInventors: Sonali Sandip Bharate, Rohit Singh, Mehak Gupta, Bikarma Singh, Anil Kumar Katare, Ajay Kumar, Sandip Bibishan Bharate, Ram Vishwakarma
-
Publication number: 20220064688Abstract: Provided herein, in some aspects, are methods and compositions for cell-free production of ribonucleic acid.Type: ApplicationFiled: March 15, 2021Publication date: March 3, 2022Applicant: GreenLight Biosciences, Inc.Inventors: William Jeremy Blake, Drew S. Cunningham, Daniel MacEachran, Mehak Gupta, James Robbins Abshire
-
Publication number: 20210309691Abstract: Provided herein, in some embodiments, are methods and composition for the production of nucleoside triphosphates and ribonucleic acids.Type: ApplicationFiled: November 10, 2020Publication date: October 7, 2021Applicant: GreenLight Biosciences, Inc.Inventors: Drew S. Cunningham, Daniel MacEachran, James Robbins Abshire, Himanshu Dhamankar, Ifeyinwa Iwuchukwu, Mehak Gupta, Matthew Eduardo Moura, Naveen Sudharsan, Nicholas Skizim, Rachit Jain, Karthikeyan Ramachandriya
-
Publication number: 20210137841Abstract: The present invention relates to the novel formulation for sustained or delayed release of rohitukine-rich Dysoxylum binectariferum extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract/fraction of rohitukine-rich Dysoxylum binectariferum with polymers has resulted in a sustained release of the extract or fraction over a period of 16-24 hrs. The said formulations are useful in the treatment of inflammatory diseases.Type: ApplicationFiled: April 18, 2019Publication date: May 13, 2021Inventors: Sonali Sandip BHARATE, Vikas KUMAR, Mehak GUPTA, Sumit GANDHI, Ajay KUMAR, Sandip Bibishan BHARATE, Ram VISHWAKARMA
-
Patent number: 10954541Abstract: Provided herein, in some aspects, are methods and compositions for cell-free production of ribonucleic acid.Type: GrantFiled: April 6, 2017Date of Patent: March 23, 2021Assignee: GreenLight Biosciences, Inc.Inventors: William Jeremy Blake, Drew S. Cunningham, Daniel MacEachran, Mehak Gupta, James Robbins Abshire
-
Publication number: 20200390843Abstract: The present invention is related to the novel oral dosage form for sustained release of crocin-1, a active constituent of Crocus sativus extract or fraction and a process for preparing the same wherein the extract is wet-granulated using excipients, biodegradable polymers and/or non-biodegradable polymers alone or in combination. The said formulations are useful for the treatment of chronic inflammatory diseases wherein NLRP3 inflammasome is involved.Type: ApplicationFiled: October 18, 2018Publication date: December 17, 2020Inventors: Sonali Sandip BHARATE, Vikas KUMAR, Rohit SINGH, Sarita RANI, Mehak GUPTA, Ajay KUMAR, Sandip Bibishan BHARATE, Ram VISHWAKARMA
-
Patent number: 10858385Abstract: Provided herein, in some embodiments, are methods and composition for the production of nucleoside triphosphates and ribonucleic acids.Type: GrantFiled: November 20, 2018Date of Patent: December 8, 2020Assignee: GreenLight Biosciences, Inc.Inventors: Drew S. Cunningham, Daniel MacEachran, James Robbins Abshire, Himanshu Dhamankar, Ifeyinwa Iwuchukwu, Mehak Gupta, Matthew Eduardo Moura, Naveen Sudharsan, Nicholas Skizim, Rachit Jain, Karthikeyan Ramachandriya
-
Publication number: 20200316150Abstract: The present invention is related to a novel gastroretentive swellable oral dosage form for sustained or delayed release of bergenin, a active constituent of Bergenia ciliata extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract of bergenin-rich Bergenia ciliata with polymers has resulted in a sustained release of extract in the stomach over a period of 16-24 hrs. The said formulations are useful for the treatment of inflammatory diseases.Type: ApplicationFiled: September 11, 2018Publication date: October 8, 2020Inventors: Sonali Sandip Bharate, Rohit Singh, Mehak Gupta, Bikarma Singh, Anil Kumar Katare, Ajay Kumar, Sandip Bibishan Bharate, Ram Vishwakarma
-
Publication number: 20190144489Abstract: Provided herein, in some embodiments, are methods and composition for the production of nucleoside triphosphates and ribonucleic acids.Type: ApplicationFiled: November 20, 2018Publication date: May 16, 2019Applicant: GreenLight Biosciences, Inc.Inventors: Drew S. Cunningham, Daniel MacEachran, James Robbins Abshire, Himanshu Dhamankar, Ifeyinwa Iwuchukwu, Mehak Gupta, Matthew Eduardo Moura, Naveen Sudharsan, Nicholas Skizim, Rachit Jain, Karthikeyan Ramachandriya
-
Publication number: 20170292138Abstract: Provided herein, in some aspects, are methods and compositions for cell-free production of ribonucleic acid.Type: ApplicationFiled: April 6, 2017Publication date: October 12, 2017Applicant: GreenLight Biosciences, Inc.Inventors: William Jeremy Blake, Drew S. Cunningham, Daniel MacEachran, Mehak Gupta, James Robbins Abshire